Drug intelligence / Profile preview

ketorolac + ibuprofen

Development stage
Unknown
Lead developer
Roche
Modality
Small Molecules
Administration
Intramuscular, Intranasal, Intravenous, Ophthalmic, Oral, Rectal, Topical
01

Overview

Ketorolac + ibuprofen is a combination of two nonsteroidal anti-inflammatory drugs (NSAIDs): ketorolac and ibuprofen. Both agents act by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), leading to decreased synthesis of prostaglandins, which are mediators of pain, inflammation, and fever. Ketorolac is typically used for short-term management of moderate to severe pain, often postoperatively, while ibuprofen is widely used for mild to moderate pain and inflammation. Combining these two NSAIDs does not provide additional analgesic benefit but significantly increases the risk of serious adverse effects such as gastrointestinal bleeding, ulceration, kidney damage, and other NSAID-related toxicities. Clinical guidelines strongly advise against the concurrent use of ketorolac with other NSAIDs like ibuprofen due to these risks[1][2][7][9].

Brand names
ToradolAdvilMotrin
Other names
NSAIDsketorolacibuprofenNSAIDs-University of Colorado, Denver-postoperative pain
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on ketorolac + ibuprofen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ketorolac + ibuprofen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call